MedSwitcher
FDA-ApprovedOral tablet

Rybelsus

semaglutide (oral) · Novo Nordisk

Choose your next step

Research the details now, then get alerts and treatment options for Rybelsus when you are ready to act.

Get Rybelsus pricing and access updates by email

Key Facts

Form

Oral tablet

Frequency

Once daily (morning, on empty stomach)

Available Doses

3mg7mg14mg

FDA Approval Date

September 20, 2019

Mechanism

GLP-1 receptor agonist (peptide, oral formulation)

Manufacturer

Novo Nordisk

Cost

Self-Pay

~$936/mo

Covered by insurance for T2D. Not typically covered for weight loss (not FDA-approved for that indication).

Side Effects

Side EffectRateSource
Nausea~16-20%PIONEER trials (dose-dependent)
Diarrhea~5-10%PIONEER trials
Vomiting~5-8%PIONEER trials
Constipation~3-5%PIONEER trials
Abdominal pain~5-7%PIONEER trials

Source: PIONEER Clinical Trial Program (PIONEER 1-10)

Weight Loss Results

PIONEER trials

~4-5%

26-52 weeks · Multiple analyses

26-52 weeks

At 14mg dose in T2D patients. Limited weight loss due to lower dose and diabetes-focused patient population.

How It Works

Rybelsus works the same way as injectable semaglutide (Ozempic) once absorbed. The SNAC co-formulation protects semaglutide from stomach acid and enhances absorption. However, oral bioavailability is only ~1%, meaning the 14mg tablet delivers roughly the equivalent of a very low injectable dose.

Mechanism: Rybelsus was the first oral GLP-1 medication (approved 2019). Like oral Wegovy, it uses the SNAC absorption enhancer to enable oral delivery of semaglutide. Its maximum dose (14mg) is much lower than oral Wegovy's (25mg), limiting its weight loss efficacy. Rybelsus is approved for diabetes only.

Who It's For

Indication

Type 2 diabetes mellitus (not approved for weight loss)

Adults with type 2 diabetes who prefer an oral medication over injections. Not recommended for weight loss — oral Wegovy (higher doses) or Foundayo offer much better weight loss results. Rybelsus's main advantage is existing insurance coverage for diabetes.

Food & Water Restrictions

⚠️ Restrictions Apply

Must take on an empty stomach with ≤4oz plain water. Wait 30 minutes before eating, drinking, or taking other medications.

Switching Guides

Comparisons

Helpful Articles

Rybelsus fact review snapshot
Medication
Rybelsus
Tracked facts
7
Human verified
0
Last refreshed: 2026-04-07

This page pulls from MedSwitcher's structured medication fact database. Facts are tracked separately from page copy so we can update sources, pricing, and trial details without guessing.

Primary source trail
  • Rybelsus Prescribing Information
  • PIONEER clinical program
  • Rybelsus pricing

Want the boring but important details? Read our editorial policy and methodology.

Don't miss price changes

GLP-1 prices are changing — stay ahead

Foundayo prices may increase — get alerts before they do. Track price drops, shortages, and new switching guidance without checking back manually.

  • Price increase warnings before they hit
  • Savings card and coupon alerts
  • New switching guidance and availability updates

No spam. Unsubscribe anytime. We never share your email.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Clinical trial data referenced comes from published studies and FDA prescribing information. Side effect rates are from specific clinical trials and may not reflect real-world experience. Always consult your healthcare provider before starting, stopping, or switching any medication.